Leading the Way in Life Science Technologies

GEN Exclusives

More »

Best of the Web

More »
Jun 01, 2005 (Vol. 25, No. 11)

Global Amphibian Assessment

  • Thorough
  • Nothing significant
Put a google-eyed tree frog and an incredible blue anake on the opening page and you've got the making of an interesting biology-based site. Global Amphibian Assessment aims to provide comprehensive status assessment of the 5,743 known species of amphibians in the world. At the site, you'll learn that 35 species are extinct in the wild, 427 species are critically endangered, 761 species are endangered, 668 species are vulnerable, and 359 species are near threatened. Yikes!We've all heard about the declining numbers of amphibians, but seeing the actual numbers is even more scary. The database is more than just numbers, though, with searchable information on habitats, geographic locations, and much miscellany. A disturbing collection of information.
  • Key:
  • Strong Points
  • Weak Points
  • Ratings:
  • Excellent
  • Very Good
  • Good

*The opinions expressed are solely those of the author(s) and should not be construed as reflecting the viewpoints of the publisher, Genetic Engineering & Biotechnology News, Mary Ann Liebert, Inc., the publishing house, or employees and affiliates thereof.

Be sure to take the GEN Poll

Scientifically Studying Ecstasy

MDMA (commonly known as the empathogen “ecstasy”) is classified as a Schedule 1 drug, which is reserved for compounds with no accepted medical use and a high abuse potential. Two researchers from Stanford, however, call for a rigorous scientific exploration of MDMA's effects to identify precisely how the drug works, the data from which could be used to develop therapeutic compounds.

Do you agree that ecstasy should be studied for its potential therapeutic benefits?

More »